AKT1 and myeloid sarcoma: The analysis at baseline conditions revealed a general downregulation of phosphorylated signaling proteins in MS across all peripheral cellular components, in particular p38MAPK, with the exception of Akt and Cbl, which were found upregulated in MS patients.